Results 71 to 80 of about 75,257 (296)

Survival of patients with prostate cancer and normal PSA levels treated by radical prostatectomy

International Brazilian Journal of Urology, 2005
INTRODUCTION: The unpredictability of prostate cancer has become a daily challenge for the urologist, with different strategies being required to manage these cases.
Marcos F. Dall'oglio, Alexandre Crippa, Alberto A. Antunes, Luciano J. Nesrallah, Katia R. Leite, Miguel Srougi   +5 more
doaj   +1 more source

Avaliação da incontinência urinária como complicação da cirurgia de prostatectomia radical retropúbica para tratamento do câncer de próstata. [PDF]

, 2007
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Vieira, Matheus Pereira
core  

Lipid and Foam Cell Accumulation as Novel Pathological Features of Benign Prostatic Hyperplasia

The Prostate, EarlyView.
ABSTRACT Background Benign prostatic hyperplasia (BPH) encompasses a heterogeneous set of pathological processes that instigate lower urinary tract symptoms (LUTS). Using a mouse model of steroid hormone imbalance–induced lower urinary tract dysfunction, we identified luminal lipid‐laden foamy macrophages, although their presence and contribution to ...
Dita Julianingsih, Samara V. Silver, Thaissa Horne, Kasun Gunawardena, Savannah Ward, Alicia Malewska, Douglas Strand, Julius Nyalwidhe, Ilya Sobol, Petra Popovics   +9 more
wiley   +1 more source

Design and Validation of the Marmara Post-prostatectomy Incontinence Symptom Score

, 2017
Objective: This study aims to validate the “Marmara post-prostatectomy incontinence symptom score (M-PPISS)” designed for the assessment of post-prostatectomy incontinence (PPI).
Murat Akgül, Muhammed Sulukaya, Tufan Tarcan, Ahmet Şahan, Nural Bekiroğlu, İlker Tinay, Levent Türkeri   +6 more
core   +1 more source

Prognostic Role of Serum Neuron‐Specific Enolase at Baseline and its Early Dynamics in Metastatic Castration‐Resistant Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors

The Prostate, EarlyView.
ABSTRACT Background Outcomes of metastatic castration‐resistant prostate cancer (mCRPC) treated with androgen receptor signaling inhibitors (ARSIs) vary widely and may not be fully reflected by PSA and standard clinicopathologic factors. We evaluated the prognostic value of serum neuron‐specific enolase (NSE) at baseline and early on‐treatment dynamics.
Ondřej Fiala, Michaela Tkadlecová, Zuzana Váchalová, Milan Hora, Jan Králíček, Petr Stránský Jr., Václav Liška, Matteo Santoni, Giuseppe Luigi Banna, Kristýna Pivovarčíková, Ondřej Topolčan, Jindřich Fínek   +11 more
wiley   +1 more source

Spatial Distribution of Prostate Cancer Missed by MRI‐Targeted Biopsy, Effect of a Perilesional Template, and Restaging in a Radical Prostatectomy Cohort

The Prostate, EarlyView.
ABSTRACT Purpose Systematic biopsy (SB) remains recommended in addition to MRI‐targeted biopsy (TB) because TB alone may miss clinically significant prostate cancer (sPC). We evaluated the spatial distribution of sPC and clinically insignificant prostate cancer (iPC) detected by SB in relation to MRI lesions and assessed the effect of perilesional ...
Ruth Himmelsbach, Julia Franz, Cordula Jilg, Christian Gratzke, August Sigle   +4 more
wiley   +1 more source

Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT

Health Technology Assessment, 2018
Background: Prostate cancer (PCa) is the most common cancer in men in the UK. Patients with intermediate-risk, clinically localised disease are offered radical treatments such as surgery or radiotherapy, which can result in severe side effects.
Freddie C Hamdy, Daisy Elliott, Steffi le Conte, Lucy C Davies, Richéal M Burns, Claire Thomson, Richard Gray, Jane Wolstenholme, Jenny L Donovan, Ray Fitzpatrick, Clare Verrill, Fergus Gleeson, Surjeet Singh, Derek Rosario, James WF Catto, Simon Brewster, Tim Dudderidge, Richard Hindley, Amr Emara, Prasanna Sooriakumaran, Hashim U Ahmed, Tom A Leslie   +21 more
doaj   +1 more source

Early Experience with Salvage Robotic-Assisted Radical Prostatectomy in Proton Beam Radiotherapy Failures

, 2021
Aims: To assess the perioperative and short-term functional and oncologic outcomes of the salvage robot-assisted radical prostatectomy (sRARP), after recurrence following primary proton beam therapy for clinically localized prostate ...
Murat Atar, Pisters, Lonuis L., Lonuis L. Pisters, Atar, Murat, Yaşar Bozkurt, Bozkurt, Yasar   +5 more
core   +1 more source

Efficacy, Safety, and Cost‐Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non‐Metastatic Castration‐Resistant Prostate Cancer: A Multicenter Retrospective Study

The Prostate, EarlyView.
ABSTRACT Background The introduction of novel androgen receptor signaling inhibitors (ARSIs) has substantially transformed the systemic treatment landscape for non‐metastatic castration‐resistant prostate cancer (nmCRPC). Unfortunately, ARSI therapy is associated with considerable adverse events (AEs) and high medical costs.
Himawari Asanuma, Naoki Fujita, Shumon Kato, Yohei Kawashima, Masanao Shinohara, Ryuji Tabata, Fumiya Yoneyama, Ryuma Tanaka, Takuya Oishi, Hikari Miura, Kyo Togashi, Kazutaka Okita, Hirotaka Horiguchi, Toshikazu Tanaka, Daisuke Noro, Yuichiro Suzuki, Satoshi Sato, Chikara Ohyama, Shingo Hatakeyama   +18 more
wiley   +1 more source

Association between PSA values and surveillance quality after prostate cancer surgery

Cancer Medicine, 2019
Background Although prostate‐specific antigen (PSA) testing is used for prostate cancer detection and posttreatment surveillance, thresholds in these settings differ.
Christina Hunter Chapman, Megan E. V. Caram, Archana Radhakrishnan, Alexander Tsodikov, Curtiland Deville, Jennifer Burns, Alexander Zaslavsky, Michael Chang, John T. Leppert, Timothy Hofer, Anne E. Sales, Sarah T. Hawley, Brent K. Hollenbeck, Ted A. Skolarus   +13 more
doaj   +1 more source